FABP4 and obesity disorder: Interestingly, related research has found that the novel adipokine fatty acid-binding protein 4 (FABP4), closely associated with obesity and metabolic diseases, is significantly higher in the serum and synovial fluid of patients with RA than in those of OA patients [104], while plasma and synovial fluid levels of FABP4 are significantly higher in OA patients than in those of healthy non-OA controls [105].